Tian X Zhao
Overview
Explore the profile of Tian X Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Juhasz V, Charlier F, Zhao T, Tsiantoulas D
Atherosclerosis
. 2024 Nov;
399:118616.
PMID: 39546915
Atherosclerotic disease is a cholesterol-rich lipoprotein particle-driven disease resulting in the formation of atherosclerotic plaques in large and medium size arteries. Rupture or erosion of atherosclerotic plaques can trigger the...
2.
Takaoka M, Zhao X, Lim H, Magnussen C, Ang O, Suffee N, et al.
Nature
. 2024 Sep;
634(8033):457-465.
PMID: 39231480
Hyperlipidaemia is a major risk factor of atherosclerotic cardiovascular disease (ASCVD). Risk of cardiovascular events depends on cumulative lifetime exposure to low-density lipoprotein cholesterol (LDL-C) and, independently, on the time...
3.
4.
Corovic A, Zhao X, Huang Y, Newland S, Gopalan D, Harrison J, et al.
Cardiovasc Res
. 2024 Jul;
120(14):1752-1767.
PMID: 39073768
Aims: While acute cardiovascular complications of coronavirus disease 2019 (COVID-19) are well described, less is known about longer-term cardiac sequelae. For many individuals with cardiac signs or symptoms arising after...
5.
Aetesam-Ur-Rahman M, Zhao T, Paques K, Oliveira J, Chiu Y, Duckworth M, et al.
Catheter Cardiovasc Interv
. 2024 Jul;
104(3):462-471.
PMID: 39044651
Background: Coronary microvascular dysfunction (CMD) after percutaneous coronary intervention (PCI) is prognostically important and may also be a cause of persistent angina. The stent balloon inflation technique or material properties...
6.
OBrien J, Case A, Kemper C, Zhao T, Mallat Z
Arterioscler Thromb Vasc Biol
. 2024 May;
44(7):1512-1522.
PMID: 38813699
The adaptive immune system plays an important role in the development and progression of atherosclerotic cardiovascular disease. B cells can have both proatherogenic and atheroprotective roles, making treatments aimed at...
7.
Marginal zone B cells produce 'natural' atheroprotective IgM antibodies in a T cell-dependent manner
Harrison J, Newland S, Jiang W, Giakomidi D, Zhao X, Clement M, et al.
Cardiovasc Res
. 2024 Feb;
120(3):318-328.
PMID: 38381113
Aims: The adaptive immune response plays an important role in atherosclerosis. In response to a high-fat/high-cholesterol (HF/HC) diet, marginal zone B (MZB) cells activate an atheroprotective programme by regulating the...
8.
Zhao T, Sriranjan R, Tuong Z, Lu Y, Sage A, Nus M, et al.
NEJM Evid
. 2024 Feb;
1(1):EVIDoa2100009.
PMID: 38319239
BACKGROUND: Atherosclerosis is a chronic inflammatory disease of the artery wall. Regulatory T cells (Tregs) limit inflammation and promote tissue healing. Low doses of interleukin (IL)-2 have the potential to...
9.
Inaba A, Tuong Z, Zhao T, Stewart A, Mathews R, Truman L, et al.
Nat Commun
. 2023 Apr;
14(1):2071.
PMID: 37045832
Dysfunction of interleukin-10 producing regulatory B cells has been associated with the pathogenesis of autoimmune diseases, but whether regulatory B cells can be therapeutically induced in humans is currently unknown....
10.
Aetesam-Ur-Rahman M, Zhao T, Paques K, Oliveira J, Khialani B, Kyranis S, et al.
J Am Heart Assoc
. 2022 Apr;
11(9):e023554.
PMID: 35470686
Background Post-percutaneous coronary intervention (PCI) fractional flow reserve ≥0.90 is an accepted marker of procedural success, and a cutoff of ≥0.95 has recently been proposed for post-PCI instantaneous wave-free ratio....